Prognostic value of histopathology and trends in cervical cancer: a SEER population study.
BACKGROUND
Histopathology is a cornerstone in the diagnosis of cervical cancer but the prognostic value is controversial.


METHODS
Women under active follow-up for histologically confirmed primary invasive cervical cancer were selected from the United States Surveillance, Epidemiology, and End Results (SEER) 9-registries public use data 1973-2002. Only histologies with at least 100 cases were retained. Registry area, age, marital status, race, year of diagnosis, tumor histology, grade, stage, tumor size, number of positive nodes, number of examined nodes, odds of nodal involvement, extent of surgery, and radiotherapy were evaluated in Cox models by stepwise selection using the Akaike Information Criteria.


RESULTS
There were 30,989 records evaluable. From 1973 to 2002, number of cases dropped from 1,100 new cases/year to 900/year, but adenocarcinomas and adenosquamous carcinoma increased from 100/year to 235/year. Median age was 48 years. Statistically significant variables for both overall and cause-specific mortality were: age, year of diagnosis, race, stage, histology, grade, hysterectomy, radiotherapy, tumor size and nodal ratio. The histological types were jointly significant, P < 0.001. Cause-specific mortality hazard ratios by histological type relatively to non-microinvasive squamous cell carcinoma were: microinvasive squamous cell carcinoma 0.28 (95% confidence interval: 0.20-0.39), carcinoma not otherwise specified 0.91 (0.79-1.04), non-mucinous adenocarcinoma 1.06 (0.98-1.15), adenosquamous carcinoma 1.35 (1.20-1.51), mucinous adenocarcinoma 1.52 (1.23-1.88), small cell carcinoma 1.94 (1.58-2.39).


CONCLUSIONS
Small cell carcinoma and adenocarcinomas were associated with poorer survival. The incidental observation of increasing numbers of adenocarcinomas despite a general decline suggests the inefficiency of conventional screening for these tumors. Increased incidence of adenocarcinomas, their adverse prognosis, and the young age at diagnosis indicate the need to identify women who are at risk.
Vinh-Hung
Vincent
V
Oncologisch Centrum, Universitair Ziekenhuis Brussel, 101 Laarbeeklaan, 1090 Jette, Brussels, Belgium. conrvhgv@uzbrussel.be
Bourgain
Claire
C
Vlastos
Georges
G
Cserni
Gábor
G
De Ridder
Mark
M
Storme
Guy
G
Vlastos
Anne-Thérèse
AT
D000230:Adenocarcinoma / Q000453:epidemiology; D017677:Age Distribution; D018288:Carcinoma, Small Cell / Q000453:epidemiology; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000706:statistics & numerical data; D015994:Incidence; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D016016:Proportional Hazards Models; D044469:Racial Groups / Q000706:statistics & numerical data; D011878:Radiotherapy / Q000706:statistics & numerical data; D018426:SEER Program; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000473:pathology* / Q000628:therapy
Int J Cancer. 2000 May 1;86(3):429-35
10760834
Am J Obstet Gynecol. 2003 Jul;189(1):118-20
12861148
Cancer. 1995 Nov 15;76(10 Suppl):1948-55
8634986
MMWR Morb Mortal Wkly Rep. 2002 Nov 29;51(47):1067-70
12500907
J Natl Cancer Inst. 2006 Mar 1;98(5):303-15
16507827
Br J Cancer. 2005 Nov 28;93(11):1301-4
16265348
Int J Cancer. 1998 Feb 9;75(4):536-45
9466653
CMAJ. 2001 Apr 17;164(8):1151-2
11338801
Gynecol Oncol. 1979 Apr;7(2):111-22
437563
J Pathol. 2003 Dec;201(4):535-43
14648656
Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):485-500
16150389
Gynecol Oncol. 2003 Aug;90(2):282-9
12893188
Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1129-36
11700260
Eur J Cancer. 2002 Dec;38(18):2428-34
12460788
Int J Gynecol Cancer. 2006 May-Jun;16(3):1025-31
16803480
Cancer Causes Control. 2006 Apr;17(3):299-306
16489537
N Engl J Med. 2007 May 10;356(19):1928-43
17494926
Gynecol Oncol. 2003 Dec;91(3):558-62
14675676
Am J Pathol. 2000 Oct;157(4):1055-62
11021808
J Epidemiol Community Health. 1995 Apr;49(2):153-7
7798043
Am J Surg Pathol. 1998 Jan;22(1):113-20
9422324
Vaccine. 2006 Aug 31;24 Suppl 3:S3/iii-iv
16950024
Cancer. 1986 Apr 15;57(8):1584-93
2418947
Gynecol Oncol. 1989 Nov;35(2):145-9
2807003
CA Cancer J Clin. 2007 Jan-Feb;57(1):7-28
17237032
Cancer. 2006 Oct 15;107(8):1711-42
16958083
Int J Gynecol Cancer. 2004 Sep-Oct;14(5):741-50
15361180
J Natl Cancer Inst Monogr. 2003;(31):3-13
12807939
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30
16514137
J Pathol. 1999 Sep;189(1):12-9
10451482
Lancet. 2006 Apr 15;367(9518):1247-55
16631880
Semin Surg Oncol. 1994 Jan-Feb;10(1):31-46
8115784
JAMA. 2007 Feb 28;297(8):813-9
17327523
Int J Cancer. 2002 Dec 1;102(4):412-7
12402312
Sex Transm Dis. 1999 Apr;26(4 Suppl):S2-7
10227693
Br J Cancer. 2003 Dec 1;89(11):2078-86
14647141
Breast Cancer Res. 2004;6(6):R680-8
15535850
Eur J Cancer. 2000 Nov;36(17):2266-71
11072218
Gynecol Oncol. 2002 Jan;84(1):115-9
11748986
Obstet Gynecol. 1985 Mar;65(3):416-22
3974967
Gynecol Oncol. 1996 Dec;63(3):304-11
8946863
Mod Pathol. 2005 Apr;18(4):528-34
15502807
Bull Cancer. 1998 Apr;85(4):319-27
9752295
Nat Rev Cancer. 2006 Oct;6(10):753-63
16990853
Nat Rev Cancer. 2007 Jan;7(1):11-22
17186016
J Natl Cancer Inst Monogr. 2003;(31):14-9
12807940
Curr Treat Options Oncol. 2004 Apr;5(2):119-27
14990206
Int J Cancer. 2006 Mar 15;118(6):1481-95
16206285
Br J Cancer. 2006 Jan 16;94(1):171-5
16404371
Eur J Obstet Gynecol Reprod Biol. 2002 Feb 10;101(1):64-9
11803102
Am J Obstet Gynecol. 2003 Mar;188(3):657-63
12634637
Gynecol Oncol. 1995 Oct;59(1):38-44
7557613
Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66
11602373
Acta Obstet Gynecol Scand. 2006;85(1):106-11
16521689
Cancer. 2001 Nov 1;92(9):2471-83
11745305
Lancet. 2001 May 12;357(9267):1490-3
11377601
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2191-9
16172231
Cancer. 2003 Aug 15;98(4):814-21
12910527
Cancer Detect Prev. 2004;28(6):461-4
15582270
Virus Res. 2002 Nov;89(2):191-9
12445659
N Engl J Med. 2007 May 10;356(19):1915-27
17494925
J Clin Pathol. 2002 Apr;55(4):244-65
11919208
Biomed Pharmacother. 2003 Mar;57(2):67-77
12854514
Lancet. 2002 Mar 30;359(9312):1093-101
11943256
Cancer Res. 2003 Nov 1;63(21):7215-20
14612516
J Med. 1995;26(1-2):17-30
7561528